drugset / Trial / NCT01382329
H5N1 Vaccine Study in Japanese Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to obtain immunogenicity and safety data of two different dose levels of an H5N1 pandemic influenza vaccine in a healthy Japanese adult population aged 18 to 59 years.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-08
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | H5N1 (Pre-)Pandemic Influenza Vaccine | Vaccine | — | Intramuscular |